NIPO trademark

RETEVMO

RegisteredNIPOWord markClass 5

"RETEVMO" is a word mark owned by Eli Lilly and Company, filed at the NIPO on September 6, 2019. It is registered and covers class 5 (Pharmaceuticals).

Official NIPO record
RETEVMO
Word mark as filed with the NIPO
Status
Registered
Since January 6, 2020
Filed
September 6, 2019
Registered
January 6, 2020
Expires
September 6, 2029
Application no.
201911835
Registration no.
307563
Office
NIPO
Patentstyret (Norwegian Industrial Property Office)
Mark type
Word mark
1 class
Ownership

Who owns RETEVMO

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services RETEVMO is filed for, grouped by Nice class.

  • Farmasøytiske preparater, nemlig farmasøytiske preparater for behandling av alopeci, Alzheimers sykdom, allergisk eksem, autoimmune sykdommer og lidelser, ben- og skjelettsykdommer og -lidelser, kreft, kardio-vaskulære sykdommer, sykdommer og forstyrrelser i sentralnervesystemet, cluster-hodepine, Crohns syksom, demens, dermatologiske sykdommer og forstyrrelser, diabetes, dyslipidemi, endokrine sykdommer og lidelser, gastrointestinale sykdommer og lidelser, hodepiner, hjertelammelse og hjertesvikt, hypoglykemi, betennelser og inflammatoriske sykdommer og lidelser, inflammatorisk tarmsykdom, nyresykdommer og -lidelser, leversykdommer og -lidelser, lupus, psykiske lidelser, metaboliske sykdommer og lidelser, migrene, multippel sklerose, muskelsykdommer og -lidelser, nevrodegenerative sykdommer og lidelser, nevrologiske lidelser, fedme, smerte, Parkinsons sykdom, psoriasis, psoriasis arthropatica, leddgikt, Sjøgrens syndrom, søvnforstyrrelser, spondylartropati, ulcerøs kolitt, diagnostiske midler og stoffer for medisinske formål; radiofarmasøytiske diagnostiske preparater for bruk i diagnostiseringen av nevrodegenerative sykdommer og av onkologi og av smerte.

History

What has happened so far

Steps recorded by the NIPO, newest first.

  1. Date of publication of a registered mark
FAQ

About RETEVMO

Who owns the trademark "RETEVMO"?

The NIPO trademark "RETEVMO" (application 201911835) is owned by Eli Lilly and Company.

What is the status of "RETEVMO"?

Its status at the NIPO is: registered.

When was "RETEVMO" registered?

It was registered on January 6, 2020 and is due to expire on September 6, 2029.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull RETEVMO and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019e4bd4-f34f-7655-b3ae-1a9288f51c8f
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019e4bd4-f34f-7655-b3ae-1a9288f51c8f",
  "object": "trademark",
  "mark_text": "RETEVMO",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "NO",
  "application_number": "201911835",
  "filing_date": "2019-09-06",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Eli Lilly and Company",
      "entity_id": "ent_019eb749-c2e4-7669-8d85-00996fda299e"
    }
  ]
}